Boehringer Ingelheim recalls clobutinol products
Boehringer Ingelheim is voluntarily recalling all worldwide products containing clobutinol hydrochloride, which has been on the market for 46 years, following a report questioning the drug's safety.
Archives for September 2, 2007
Eli Lilly opens door for next-generation antipsychotics
Positive results from a Phase II trial have shown that Eli Lilly's latest antipsychotic drug acts on a new target and avoids key adverse effects caused by other antipsychotics.
Pseudoephedrine drugs still OTC
Reformulations of pseudoephedrine- and ephedrine-containing drugs in the UK look unlikely following the announcement of less extreme restrictions on the sale of the pharmaceuticals.
Six-month prostate cancer drug soon to be launched
A six-month formulation of a prostate cancer drug will soon be launched in 23 European countries following its successful approval procedure.